Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis

BACKGROUND: Moyamoya disease (MMD) is a leading cause of stroke in children and young adults, whereas no specific drugs are available. Antiplatelet therapy (APT) has been considered a promising treatment option, but its effectiveness remains controversial. Therefore, we aimed to comprehensively eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingting, Qin, Mingzhen, Xiong, Xuejiao, Li, Tingting, Feng, Luda, Lai, Xinxing, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318533/
https://www.ncbi.nlm.nih.gov/pubmed/37409015
http://dx.doi.org/10.3389/fneur.2023.1132339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318533/
https://www.ncbi.nlm.nih.gov/pubmed/37409015
http://dx.doi.org/10.3389/fneur.2023.1132339

Ejemplares similares